Rosuvastatin Lowers Systemic Inflammatory Response in Coronary Artery Bypass Graft Accompanied by Cardiopulmonary Bypass Surgery: A Randomized Controlled Study. [electronic resource]
Producer: 20160823Description: E154-63 p. digitalISSN:- 1488-2353
- Adult
- Aged
- Cardiopulmonary Bypass -- adverse effects
- Cholesterol -- blood
- Coronary Artery Bypass -- adverse effects
- Drug Administration Schedule
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Interleukin-10 -- blood
- Interleukin-18 -- blood
- Interleukin-6 -- blood
- Male
- Middle Aged
- Rosuvastatin Calcium -- administration & dosage
- Systemic Inflammatory Response Syndrome -- drug therapy
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.